Could a nerve drug help botulism patients breathe easier?
NCT ID NCT01441557
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This small pilot study tested a drug called 3,4-diaminopyridine (FIRDAPSE) in 3 people with severe botulism who needed a ventilator to breathe. The goal was to see if the drug could improve nerve signals and breathing. Because only 3 people took part, the results are very preliminary and not enough to draw firm conclusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 3,4-diaminopyridine (FIRDAPSE)
- What this could lead to
- If it works, this drug could help botulism patients breathe better and recover muscle function faster.
- What could go wrong
- This was a tiny pilot study with only 3 participants, so results may not apply widely. The drug may cause side effects like seizures or heart issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BOTULISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU
Amiens, 80000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.